Reata Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, includ…
Biotechnology
US, Plano [HQ]
Strategy & Leadership

Executives & BofD Beta

Total Compensation ($)

Scope

Executives

Yet No Data For Executives

Directors

Yet No Data For Directors

C-Suite and VPs/SVPs

Yet No Data For Executives

Board of Directors (BofD)

Yet No Data For Directors

End of RETA's Analysis
CIK: 1358762 CUSIP: 75615P103 ISIN: US75615P1030 LEI: - UEI: -
Secondary Listings
RETA has no secondary listings inside our databases.